Author:
Loader Dagmara Ewa,Feldmann Robert,Baumgartner Magdalena,Breier Friedrich,Schrama David,Becker Jürgen Christian,Steiner Andreas
Reference5 articles.
1. A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331);Samlowski;Am J Clin Oncol,2010
2. Juxtamebrane mutant V560GKIT is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant;Frost;Mol Cancer Ther,2002
3. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma;Krasagakis;Anticancer Res,2011
4. Tyrosine kinase inhibitors [in French];Robert;Bull Cancer,2011
5. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma;Davids;J Clin Oncol,2009
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献